These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 26279520

  • 1. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment.
    Petrara MR, Giunco S, Serraino D, Dolcetti R, De Rossi A.
    Cancer Lett; 2015 Dec 01; 369(1):37-44. PubMed ID: 26279520
    [Abstract] [Full Text] [Related]

  • 2. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R.
    Autoimmun Rev; 2007 Dec 01; 7(2):96-101. PubMed ID: 18035317
    [Abstract] [Full Text] [Related]

  • 3. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
    Mentzer SJ, Perrine SP, Faller DV.
    Transpl Infect Dis; 2001 Sep 01; 3(3):177-85. PubMed ID: 11493400
    [Abstract] [Full Text] [Related]

  • 4. Treatment for Epstein-Barr virus-associated PTLD.
    Gross TG.
    Herpes; 2009 Jan 01; 15(3):64-7. PubMed ID: 19306606
    [Abstract] [Full Text] [Related]

  • 5. Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target.
    Tse E, Kwong YL.
    Exp Mol Med; 2015 Jan 23; 47(1):e136. PubMed ID: 25613733
    [Abstract] [Full Text] [Related]

  • 6. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients.
    Green M, Michaels MG, Webber SA, Rowe D, Reyes J.
    Pediatr Transplant; 1999 Nov 23; 3(4):271-81. PubMed ID: 10562971
    [Abstract] [Full Text] [Related]

  • 7. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP.
    Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055
    [Abstract] [Full Text] [Related]

  • 8. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Clin Infect Dis; 2013 Sep 15; 57(6):794-802. PubMed ID: 23771985
    [Abstract] [Full Text] [Related]

  • 9. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.
    Hsieh WS, Lemas MV, Ambinder RF.
    Transpl Infect Dis; 1999 Sep 15; 1(3):204-12. PubMed ID: 11428990
    [Abstract] [Full Text] [Related]

  • 10. In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.
    Gonzalez-Farre B, Rovira J, Martinez D, Valera A, Garcia-Herrera A, Marcos MA, Sole C, Roue G, Colomer D, Gonzalvo E, Ribera-Cortada I, Araya M, Lloreta J, Colomo L, Campo E, Lopez-Guillermo A, Martinez A.
    Mod Pathol; 2014 Dec 15; 27(12):1599-611. PubMed ID: 24762547
    [Abstract] [Full Text] [Related]

  • 11. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015 Dec 15; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 12. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients.
    Wareham NE, Mocroft A, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Iversen M, Kirkby NS, Rasmussen A, Sørensen SS, Lundgren JD, MATCH in PERSIMUNE study group.
    J Cancer Res Clin Oncol; 2018 Aug 15; 144(8):1569-1580. PubMed ID: 29804164
    [Abstract] [Full Text] [Related]

  • 13. Prompt diagnosis and management of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder and hemophagocytosis: A dreaded complication in a post-liver transplant child.
    Jha B, Mohan N, Gajendra S, Sachdev R, Goel S, Sahni T, Raina V, Soin A.
    Pediatr Transplant; 2015 Nov 15; 19(7):E177-80. PubMed ID: 26184957
    [Abstract] [Full Text] [Related]

  • 14. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
    Shaknovich R, Basso K, Bhagat G, Mansukhani M, Hatzivassiliou G, Murty VV, Buettner M, Niedobitek G, Alobeid B, Cattoretti G.
    Haematologica; 2006 Oct 15; 91(10):1313-20. PubMed ID: 17018379
    [Abstract] [Full Text] [Related]

  • 15. Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder.
    Kroll J, Li S, Levi M, Weinberg A.
    J Clin Virol; 2011 Nov 15; 52(3):231-5. PubMed ID: 21900040
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus infection and altered control of apoptotic pathways in posttransplant lymphoproliferative disorders.
    Ghigna MR, Reineke T, Rincé P, Schüffler P, El Mchichi B, Fabre M, Jacquemin E, Durrbach A, Samuel D, Joab I, Guettier C, Lucioni M, Paulli M, Tinguely M, Raphael M.
    Pathobiology; 2013 Nov 15; 80(2):53-9. PubMed ID: 22868923
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
    Romero S, Montoro J, Guinot M, Almenar L, Andreu R, Balaguer A, Beneyto I, Espí J, Gómez-Codina J, Iacoboni G, Jarque I, López-Andújar R, Mayordomo-Aranda E, Montalar J, Pastor A, Pastor M, Piñana JL, Rojas-Ferrer N, Sánchez-Lázaro I, Sandoval J, Sanz G, Sanz MÁ, Solé A, Sanz J.
    Leuk Lymphoma; 2019 Jan 15; 60(1):142-150. PubMed ID: 29966464
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
    Zallio F, Primon V, Tamiazzo S, Pini M, Baraldi A, Corsetti MT, Gotta F, Bertassello C, Salvi F, Rocchetti A, Levis A.
    Clin Transplant; 2013 Jan 15; 27(4):E491-7. PubMed ID: 23781897
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.
    Liu QF, Fan ZP, Luo XD, Sun J, Zhang Y, Ding YQ.
    Transpl Infect Dis; 2010 Aug 01; 12(4):284-91. PubMed ID: 20345506
    [Abstract] [Full Text] [Related]

  • 20. Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder.
    Zaffiri L, Frankel C, Bush EJ, Neely ML, Pavlisko EN, Mokrova IL, Luftig MA, Palmer SM.
    J Med Virol; 2021 Aug 01; 93(8):5040-5047. PubMed ID: 33704812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.